Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04741230Not ApplicableRecruiting

Investigator Initiated, Prospective Study of Xenia Corneal Lenticule

Role: collaborator

NCT01670487Not ApplicableCompleted

Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients

Role: collaborator

NCT01712776Not ApplicableCompleted

Vapocoolant (Pain Ease) Use for Venipuncture

Role: collaborator

NCT04207710Phase 4Completed

Safety of Gebauer's Pain Ease and Gebauer's Ethyl Chloride

Role: collaborator

All 4 trials loaded